Identification of a hepatocyte growth factor autocrine loop in a murine mammary carcinoma

Cell Growth and Differentiation

Volumn 7, Issue 2, 1996, Pages 263-270

  Rahimi, Nader ^a   Tremblay, Eric ^a   McAdam, Laura ^a   Park, Marg ^b   Schwall, Ralph ^c   Elliott, Bruce ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b ROYAL VICTORIA HOSPITAL   (Canada)

^c GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; SCATTER FACTOR;

ANIMAL CELL; ARTICLE; BREAST CARCINOMA; CANCER GROWTH; GROWTH REGULATION; METASTASIS POTENTIAL; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION; TISSUE DISTRIBUTION;

3T3 CELLS; ADIPOCYTES; ANIMALS; ANTINEOPLASTIC AGENTS; DOGS; FEMALE; HEPATOCYTE GROWTH FACTOR; KIDNEY TUBULES, DISTAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED CBA; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-MET; RECEPTOR PROTEIN-TYROSINE KINASES; RNA, MESSENGER; SIGNAL TRANSDUCTION; STROMAL CELLS; SURAMIN; TYROSINE;

EID: 0030030065     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Todaro, G., Fryling, C., and De Larco, J. Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors. Proc. Natl. Acad. Sci. USA, 77: 5258-5262, 1980.
2. Downward, J., Yarden, Y , Mayes, E., Scrace, G., Totty, N., Stockwell, P , Ullrich, A., Schlessinger, J., and Waterfield, M. Close similarity of epidermal growth factor receptor and v-erbB oncogene protein sequences. Nature (Lond.), 307: 521-527, 1984.
3. Libermann, T. A., Friesel, R., Jaye, M., Lyall, R. M , Westermark, B., Drohan, W , Schimdt, A., Maciag, T., and Schlessinger, J. An angiogenic growth factor is expressed in human glioma cells EMBO J., 6: 1627-1632, 1987.
4. Sherr, C. J., Rettenmier, C. W., Sacca, R., Roussel, M. F., Look, A. Y., and Stanley, E. R. The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor CSF-1. Cell, 41: 665-676, 1985.
5. Sefton, B. M. Oncogenes encoding protein kinases. In: R. A Bradshaw and S. Prentis (eds.), Oncogenes and Growth Factors, pp. 241-253. Amsterdam: Elsevier Biomedical Press, 1987.
6. Betsholtz, C , Heldin, C-H., Nister, M., Ek, B., Wasteson, A., and Westermark, B. Co-expression of a PDGF-like growth factor and PDGF receptors in a human osteosarcoma cell line: implication for autocrine receptor activation. Cell, 39: 447-457, 1984.
7. Cuttitta, F., Carney, D. N., Mulshine, J., Moody, T. W., Fedorko, J., Fischler, A., and Minna, J. D. Bombesin-like peptides can function as autocrine growth factors in human small cell lung cancer. Nature (Lond.), 216: 823-826, 1985.
8. Sporn, M. B., and Roberts, A. B. Autocrine growth factors and cancer. Nature (Lond.), 313: 745-747, 1985.
9. Sporn, M B , and Todaro, G. J. Autocrine secretion and malignant transformation of cells N. Engl. J. Med., 303: 878-880, 1980.
10. Mizuno, K , and Nakamura, T. Molecular characteristics of HGF and the gene, and its biological aspects. EXS, 65: 1-29, 1993.
11. Matsumoto, K., and Nakamura, T. Role of hepatocyte growth factor as a pleiotropic factor in organ regeneration. EXS, 65: 225-249, 1993.
12. Grant, D. S., Kleinman, H. K., Goldberg, I. D., Bhargava, M. M., Polvenni, P., and Rosen, E. M. Scatter factor induces blood vessel formation in vivo. Proc. Natl. Acad. Sei. USA. 90: 1937-1941, 1993.
13. Stocker, M., Gherardi, E., Perryman, M., and Gray, I. Scatter factor is a fibroblast-derived modulator of epithelial cell motility. Nature (Lond.), 324: 239-249, 1987.
14. Weidner, K. M., Behrens, J , Vandekerckhove, J., and Birchmeier, W. Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells. J. Cell Biol., 111: 2097-2108, 1990.
15. Sonnenberg, E., Meyer, D., Weidner, K. M., and Birchmeier, C. Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development J. Cell Biol., 123: 223-235, 1993.
16. Sonnenberg, E., Weidner, K. M., and Birchmeier, C. Expression of the met-receptor and its ligand HGF-SF during mouse embryogenesis. EXS, 65: 381-394, 1993.
17. Adams, J. C., Furlong, R. A., and Watt, F. M. Production of scatter factor by NDK, a strain of epithelial cells, and inhibition of scatter factor activity by suramin. J. Cell Sci., 98: 385-394, 1991.
18. Tsao, M-S., Zhu, H., Giaid, A., Vaillet, J., Nakamura, T., and Park, M. Hepatocyte growth factor/scatter factor is an autocrine factor for human normal bronchial epithelial and lung carcinoma cells. Cell Growth & Differ., 4: 571-579, 1993.
19. Itakura, Y., Yamamoto, T., Matsumoto, K , and Nakamura, T. Autocrine stimulation of motility in SBC-5 human lung carcinoma cells by a two-kringle variant of HGF. Cancer Lett., 83: 235-243, 1994.
20. Bottaro, D. P., Rubin, J. S., Faletto, D. L., Chan, A. M., Kmiecik, T. E., Vande Woude, G. F., and Aaronson, S. A. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science (Washington DC), 251: 802-804, 1991.
21. Naldini, L., Vigna, E., Narsimhan, R. P , Guadino, G., Zamegar, R., Michalopoulos, G. K., and Comoglio, P. M. Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene, c-met. Oncogene, 6: 501-504, 1991.
22. Di Renzo, M. F., Olivero, M., Katsaros, D., Crepatdi, T., Gaglia, P., Zola, P., Sismondi, P., and Comoglio, P. M. Overexpression of the met/ HGF receptor in ovarian cancer. Int J. Cancer, 58: 658-662, 1994.
23. Di Renzo, M. F., Olivero, M., Giacomini, A., Porte, H., Chastre, E., Mirossay, L., Nordlinger, B., Bretti, S., Bottardi, S , Giordano, S., Plebani, M., Gespach, C., and Comoglio, P. M. Overexpression and amplification of the Met/HGF receptor gene during the progression of colorectal cancer. Clin. Cancer Res., 1: 147-154, 1995.
24. Giordano, S., Ponzetto, C., Di Renzo, M. F , Copper, C. S., and Comoglio, P M. Tyrosine kinase receptor is indistinguishable from the c-met protein. Nature (Lond.). 339: 155-156, 1989.
25. Park, M., Dean, M., Kaul, K., Braun, M. J., Gonda, M. A., and Vande Woude, G. F. Sequence of met proto-oncogene cDNA has features characteristic of the tyrosine kinase family of growth factor receptors. Proc. Natl. Acad. Sci. USA, 84: 6379-6383, 1987.
26. Di Renzo, M. F., Olivero, M., Ferro, S., Prat, M., Bongarzone, I., Pilotti, S., Belfiore, A., Constantio, A., Vigneri, R., Pierotti, M. A., and Comoglio, P. M. Overexpression of the c-met/HGF receptor gene in human thyroid carcinomas. Oncogene, 7: 2549-2553, 1992.
27. Liu, K. X., Kato, Y., Yamazaki, M., Higuchi, O., Nakamura, T., and Sugiyama, Y. Importance of the liver in plasma clearance of hepatocyte growth factors in rats. Am. J. Physiol., 263: G642-G649, 1992.
28. Natali, P. G., Nicotra, M. R., Di Renzo, M. F., Prat, M., Bigotti, A., Cavaliere, R., and Comoglio, P. M. Expression of the c-met/HGF receptor in human melanocytic neoplasms: demonstration of the relationship to malignant melanoma tumor progression. Br. J. Cancer, 68: 746-750, 1993.
29. Ferraccini, R., Di Renzo, M. F., Scotlandi, K., Baldini, N., Olivero, M., Lollini, P., Cremona, O., Campanacci, M., and Comoglio, P. M. The Met/HGF receptor is over-expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit. Oncogene, 10: 739-749, 1995.
30. Tuck, A., Park, M., Sterns, E., and Elliott, B. Co-expression of hepatocyte growth factor and receptor in human breast carcinoma. Am. J. Pathol., 148: 225-232, 1996.
31. Elliott, B. E., Tam, S-P., Dexter, D., and Chen, Z. Q. Capacity of adipose tissue to promote growth and metastasis of a murine mammary carcinoma: effect of estrogen and progesterone. Int J. Cancer, 51: 416-424, 1992.
32. Rahimi, N., Saulnier, R., Nakamura, T., Park, M., and Elliott, B. Role of hepatocyte growth factor in breast cancer: a novel mitogenic factor secreted by adipocytes. DNA Cell Biol., 13: 1189-1197, 1994.
33. Fixman, E. D., Naujokas, M A., Rodrigues, G. A., Moran, M. F., and Park, M. Efficient cell transformation by the Tpr-Met oncoprotein is dependent upon tyrosine 489 in the carboxy-terminus. Oncogene, 10: 237-249, 1995.
34. Ihle, J. N., and Kerr, I. M. Jaks and Stats in signaling by the cytokine receptor super-family. Trends Genet., 11: 69-74, 1995.
35. Wong, W. T., Kraus, M. H., Carlomagno, F., Zelano, A , Druck, T., Croce, C. M., Huebner, K., and Di Fiore, P P. The human eps15 gene, encoding a tyrosine kinase substrate, is conserved in evolution and maps to 1p31-p32. Oncogene, 9: 1591-1597, 1994.
36. Sturani, E., Zippel, R., Toschi, L. Comoglio, P. M , and Alberghina, L. Kinetics and regulation of the tyrosine-phosphorylation of epidermal growth factor receptor in intact A431 cells. Mol. Cell. Biol., 8: 1345-1351, 1988.
37. Giordano, S., Di Renzo, M. F , Ferraccini, R., Chiado-Piat, L., and Comoglio, M. P. p145, a protein with associated tyrosine kinase activity in a human gastric carcinoma cell line. Mol Cell. Biol., 8: 3510-3517, 1988.
38. Stein, C. A. Suramin: a novel anti-neoplastic agent with multiple potential mechanisms of action. Cancer Res., 53: 2239-2248, 1993.
39. S/S of simian sarcoma virus. Nature (Lond.), 304: 35-39, 1983.
40. Browder, T. M., Abrams, J. S., Wong, P. M. C., and Nienhuis, A. W. Mechanism of autocrine stimulation in hematopoietic cells producing interleukin-3 after retrovirus-mediated gene transfer. Mol. Cell. Biol., 9: 204-213, 1989.
41. Stocking, C., Loliger, C., Kawai, M , Sucic, S., Gough, N., and Ostertag, W. Identification of genes involved in growth autonomy of hematopoietic cells by analysis of factor-independent mutants. Cell, 53: 869-879, 1988.
42. Rong, S., Bodescot, M., Blair, D., Dunn, J., Nakamura, T., Mizuno, K , Park, M., Chan, A., Aaronson, S., and Vande Woude, G. F. Tumorigenicity of the met protooncogene and the gene for hepatocyte growth factor. Mol. Cell. Biol., 12: 5152-5158, 1992.
43. Yamashita, J-I., Ogawa, M., and Beppu, T. Immunoreactive hepatocyte growth factor is present in tissue extracts from human breast cancer but not in conditioned medium of human breast cancer cell lines. Res. Commun. Chem. Pathol. Pharmacol., 82: 249-252, 1993.
44. Yamashita, J-I., Ogawa, M.: Yamashita, S-I., Nomura, K., Kuramoto, M., Saishoji, T., and Shin, S. Immunoreactive hepatocyte growth factor is astrong independent predictor of recurrence and survival in human breast cancer. Cancer Res., 54: 1630-1633, 1994.
45. Tsarfaty, I., Resau, J. H., Rulong, S., Keydar, I., Faletto, D. L., and Vande Woude, G. F The met proto-oncogene receptor and lumen formation. Science (Washington DC), 257: 1258-1261, 1992.
46. Wang, Y., Selden, C., Morgan, N., Stamp, G., and Hodgson, H. J Hepatocyte growth factor expression in human mammary epithelium. Am. J. Pathol., 144: 675-682, 1994.
47. Decker, S. J., Ellis, C., Pawson, T., and Velu, T. Effects of substitution of threonine 654 of the epidermal growth factor receptor on epidermal growth factor-mediated activation of phospholipase C. J. Biol. Chem., 265: 7009-7015, 1990.
48. Yang, M. X., and Park, M. Expression of the c-met/hepatocyte growth factor/scatter factor receptor and its ligand during differentiation of murine P19 embryonal carcinoma cells. Dev. Biol., 157. 308-320, 1989.
49. Carlow, D. A., Kerbel, R. S., Feltis, J. T., and Elliott, B. Enhanced expression of class I major histocompatibility complex gene products on immunogenic variants of a spontaneous murine carcinoma. J. Natl. Cancer Inst., 75: 291-301, 1985.
50. Hendrix, M. J , Seftor, E A., Seftor, R. E., Misiorowski, R L, Saba, P. Z., Sundareshan, P., and Welch, D. R. Comparison of tumor cell invasion assays: human amnion versus reconstituted basement membrane barriers invasion & Metastasis, 9: 278-297, 1989.
51. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning, Ed. 2, pp. 7.3-7.84 Ann Arbor, MI: Cold Spring Harbor Laboratory, 1989.